CURATOLO, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 62.737
EU - Europa 4.068
AS - Asia 1.238
SA - Sud America 40
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 7
Totale 68.118
Nazione #
US - Stati Uniti d'America 62.686
UA - Ucraina 849
DE - Germania 710
IE - Irlanda 660
CN - Cina 471
IT - Italia 471
FR - Francia 315
KR - Corea 288
GB - Regno Unito 254
SG - Singapore 201
FI - Finlandia 190
RU - Federazione Russa 160
PL - Polonia 158
SE - Svezia 106
JP - Giappone 56
NL - Olanda 45
TW - Taiwan 43
CA - Canada 35
IN - India 30
HK - Hong Kong 27
TR - Turchia 27
BE - Belgio 26
CZ - Repubblica Ceca 26
ES - Italia 22
PT - Portogallo 22
MX - Messico 16
ID - Indonesia 15
AU - Australia 14
GR - Grecia 13
RO - Romania 13
BR - Brasile 10
IR - Iran 10
CL - Cile 9
CH - Svizzera 8
IL - Israele 8
IQ - Iraq 8
MY - Malesia 8
VN - Vietnam 8
EC - Ecuador 7
CO - Colombia 6
EU - Europa 6
KG - Kirghizistan 6
NZ - Nuova Zelanda 5
PE - Perù 5
PK - Pakistan 5
HU - Ungheria 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AR - Argentina 3
AT - Austria 3
BD - Bangladesh 3
EG - Egitto 3
KW - Kuwait 3
NO - Norvegia 3
PH - Filippine 3
SA - Arabia Saudita 3
AM - Armenia 2
DK - Danimarca 2
ET - Etiopia 2
LB - Libano 2
LK - Sri Lanka 2
OM - Oman 2
SM - San Marino 2
UZ - Uzbekistan 2
AL - Albania 1
BG - Bulgaria 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
LT - Lituania 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
SI - Slovenia 1
Totale 68.118
Città #
Woodbridge 19.260
Wilmington 17.591
Houston 14.553
Fairfield 2.385
Ann Arbor 1.524
Ashburn 971
Seattle 892
Chandler 852
Cambridge 845
Jacksonville 738
Dublin 622
Medford 490
Dearborn 439
Beijing 267
Lawrence 233
Kraków 155
Rome 146
New York 145
Singapore 129
San Diego 110
Menlo Park 102
Norwalk 97
Mülheim 87
Moscow 78
Milan 49
Redwood City 47
London 40
Taipei 40
University Park 38
Zhengzhou 36
Verona 31
Falls Church 28
Saint Petersburg 26
Boardman 25
Brno 25
Mountain View 25
Nanjing 25
San Mateo 20
Seoul 19
Toronto 19
Brussels 16
Hefei 16
Kunming 16
Hong Kong 15
Detroit 14
Los Angeles 14
Munich 13
Nuremberg 13
Nürnberg 13
Guangzhou 12
Konya 12
Phoenix 12
Redmond 12
Creede 11
Del Norte 11
Helsinki 11
Xalapa 11
Lappeenranta 10
Nanchang 10
Palo Alto 10
Shanghai 10
Athens 9
Bari 9
Wuhan 9
Indiana 8
San Francisco 8
Santa Clara 8
Ankara 7
Aveiro 7
Chicago 7
Council Bluffs 7
Jinan 7
Laguna Niguel 7
Lisbon 7
Southall 7
Hounslow 6
Kuala Lumpur 6
Quito 6
Turin 6
Chennai 5
Chiswick 5
Kilburn 5
New Bedfont 5
Parma 5
Salt Lake City 5
Tokyo 5
Waanrode 5
Zaragoza 5
Bozeman 4
Busto Arsizio 4
Dong Ket 4
Dronten 4
Hanoi 4
Hyderabad 4
Islington 4
Madrid 4
Nashville 4
Paris 4
Pavullo Nel Frignano 4
Pune 4
Totale 63.690
Nome #
Current role of perampanel in pediatric epilepsy 476
Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study 443
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions 429
Are caesarean sections, induced labor and oxytocin regulation linked to Autism Spectrum Disorders 420
Human endogenous retroviruses and ADHD 419
Tourette Syndrome and comorbid ADHD: Current pharmacological treatment options. 417
Association study of autistic disorder and chromosome 16p 416
Impairment in flexible regulation of speed and accuracy in children with ADHD 415
ADHD and epilepsy in children with Tourette syndrome: a triple comorbidity? 413
Two epileptic syndromes, one brain: Childhood absence epilepsy and benign childhood epilepsy with centrotemporal spikes 411
Tourette syndrome and comorbid ADHD: causes and consequences 411
Association between presenilin-1 -48C/T polymorphism and Down's syndrome 410
Reduction in Retinal Nerve Fiber Layer Thickness in Young Adults with Autism Spectrum Disorders 410
mTOR Inhibitors in Tuberous Sclerosis Complex. 407
Neurological and neuropsychiatric aspects of tuberous sclerosis complex. 406
Comorbidity of ADHD and dyslexia. 404
Adhd and human endogenous retroviruses 401
Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. 400
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. 400
MTHFR C677T and A1298C polymorphisms and cerebral stroke in two twin gestations 398
Website and Headache: Assessment of The Information Quality using the DISCERN Tool 398
Management of epilepsy in tuberous sclerosis complex 396
Oxygen exchange and energy metabolism in erythrocytes of Rett syndrome and their relationships with respiratory alterations 395
Medical treatment in children with central nervous system malformations 393
The association of rs4307059 and rs35678 markers with autism spectrum disorders is replicated in Italian families 393
Principal pathogenetic components and biological endophenotypes in autism spectrum disorders. 392
Neurological soft signs are associated with attentional dysfunction in children with attention deficit hyperactivity disorder 391
Conceptual and methodological challenges for neuroimaging studies of autistic spectrum disorders. 390
Use of the DISCERN tool for evaluating web searches in childhood epilepsy. 389
Candidate gene study of HOXB1 in autism spectrum disorder. 388
Cluster analysis of autistic patients based on principal pathogenetic components. 388
Current role of melatonin in pediatric neurology: Clinical recommendations 388
Convulsive disorder and the genetics of signal transduction; a study of a low molecular weight protein tyrosine phosphatase in a pediatric sample 387
Cortical maldevelopment in congenital cytomegalovirus infection transmitted by a woman with preexisting immunity. 387
Optical coherence tomography and infrared images of astrocytic hamartomas not revealed by funduscopy in tuberous sclerosis complex 386
Neurological soft signs are associated with attentional dysfunction in children with attention deficit hyperactivity disorder 386
Interstitial deletion of a proximal 3p: a clinically recognisable syndrome 385
Methylphenidate-induced visual hallucinations. 385
Efficacy of intensive versus nonintensive physiotherapy in children with cerebral palsy: a meta-analysis. 382
Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations. 382
Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC 382
Long term clinical course of Tourette syndrome. 381
Child neurology: role of the International Association. 381
Convulsive disorder and genetic polymorphism. Association of idiopathic generalized epilepsy with haptoglobin polymorphism 380
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders. 379
Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex. 379
Epilepsy in tuberous sclerosis complex. 378
Association of adenosine deaminase polymorphism with mild mental retardation 378
Synapses as therapeutic targets for autism spectrum disorders: an international symposium held in pavia on july 4th, 2014. 378
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 377
Urinary p-cresol is elevated in small children with severe autism spectrum disorder. 376
Hypnic headache in children. 375
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. 375
Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial 375
Two-loci ADA haplotypes in autistic disorder 374
Epilepsy associated with autism and attention deficit hyperactivity disorder: is there a genetic link? 374
Benign childhood epilepsy with centrotemporal spikes and the multicomponent model of attention: a matched control study. 373
Mammalian Target of Rapamycin Inhibitors and Life-Threatening Conditions in Tuberous Sclerosis Complex. 371
Planning deficit in children with neurofibromatosis type 1: a neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)? 370
Effectiveness of community-based treatment on clinical outcome in children with autism spectrum disorders: An Italian prospective study. 370
Long-term neurological outcome of a sextuplet pregnancy. 369
Is mTOR inhibition a systemic treatment for tuberous sclerosis? 368
Lack of association between MTHFR C677T and MTHFR A1298C genetic polymorphisms and mental retardation 367
Early-onset pure absence epilepsy: a distinct epileptic syndrome. 367
TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients. 366
Attention and executive functions profile in childhood absence epilepsy. 365
Lack of association between IDE genetic variability and Down's syndrome 364
Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: Significant clinical improvement during tamoxifen treatment 363
Refractory absence seizures: An Italian multicenter retrospective study 363
Late-onset epileptic spasms in children with Pallister-Killian syndrome: a report of two new cases and review of the electroclinical aspects. 362
Neurobehavioral phenotype observed in KBG syndrome caused by ANKRD11 mutations 361
Clinical Reasoning: A girl presenting with stiffness episodes during sleep, café-au-lait spots, and flecked retina 361
Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex 358
Rufinamide in refractory childhood epileptic encephalopathies other than Lennox-Gastaut syndrome 358
Detection of auto-antibodies to DAT in the serum: interactions with DAT genotype and psycho-stimulant therapy for ADHD. 357
Headache and attention deficit and hyperactivity disorder in children: common condition with complex relation and disabling consequences 357
Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor 356
Autism in tuberous sclerosis 355
Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation 355
Preterm birth and neurodevelopmental outcome: a review 353
MRI appearance of Sturge-Weber syndrome in tuberous sclerosis complex: is the neural crest the culprit? 353
Genotype/Phenotype Correlations in Tuberous Sclerosis Complex. 353
Attention and executive functions profile in drug naive ADHD subtypes 352
Syndromic autism: Causes and pathogenetic pathways 352
Tourette syndrome and comorbid conditions: a spectrum of different severities and complexities 352
Autism: evidence of association with adenosine deaminase genetic polymorphism 351
Can biological components predict short-term evolution in Autism Spectrum Disorders? A proof-of-concept study 351
The relationship between sleep and epilepsy: the effect on cognitive functioning in children. 350
Genetic polymorphism and idiopathic generalized epilepsy. Evidence of interaction between haptoglobin and ACP1 systems 349
Recommendations for early diagnosis and intervention in autism spectrum disorders: an Italian-Israeli consensus conference 349
Rufinamide for refractory focal seizures: an open-label, multicenter European study. 348
De novo mosaic ring chromosome 18 in a child with mental retardation, epilepsy and immunological problems 347
HERVs expression in autism spectrum disorders 347
Combined targeted treatment in early onset epilepsy associated with tuberous sclerosis 346
Mild Wolf-Hirschhorn phenotype in a girl with unbalanced t(4p;12p) translocation without seizures. 345
Hepatocellular adenoma associated with long-term exposure to phenobarbital: a paediatric case report. 345
Introduction. 344
Altered anandamide degradation in attention-deficit/hyperactivity disorder 343
Autism and metabolic diseases 343
White matter disruption is associated with persistent seizures in tuberous sclerosis complex 341
Totale 37.799
Categoria #
all - tutte 128.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.371


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017.747 0 1.703 1.316 1.797 1.680 2.024 1.668 1.761 1.669 1.630 1.170 1.329
2020/202110.899 1.257 1.399 1.144 1.421 1.024 1.186 1.312 1.031 269 281 453 122
2021/20222.064 96 205 84 45 48 205 114 80 209 182 183 613
2022/20232.490 273 205 62 237 217 628 252 155 209 17 173 62
2023/20241.017 135 42 55 26 76 211 65 48 33 45 82 199
2024/2025208 170 38 0 0 0 0 0 0 0 0 0 0
Totale 68.650